Enfusion, Inc. ("Enfusion") (NYSE: ENFN), a leading provider of software-as-a-service (SaaS) solutions for investment managers, today announced that Enfusion’s Chief Financial Officer, Brad ...

Investing.com -- Morgan Stanley downgraded Enfusion Inc (NYSE:ENFN) stock to "Equal-weight" from "Overweight" following Clearwater Analytics' proposed $1.5 billion acquisition at $11.25 per share.

Enfusion management expects preliminary full year 2024 revenue of ~$201M-202M, representing 15-16% year-on-year growth, and preliminary annual recurring revenue as of December 31, 2024, of ~$210M ...

(RTTNews) - Clearwater Analytics (CWAN) and Enfusion (ENFN) announced a definitive merger agreement for Clearwater to acquire Enfusion. Enfusion shareholders will receive consideration equal to $ ...

(Reuters) -Clearwater Analytics has agreed to acquire Enfusion in a $1.5 billion cash-and-stock deal as the financial software maker looks to bolster its international presence and enter the hedge ...

Clearwater, which says it has obtained an $800 million loan to fund the transaction, along with a $200 million revolving line of credit, will let Enfusion's shareholders elect to receive cash ...

The two firms have inked a definitive merger agreement for Clearwater to acquire Enfusion for $11.25 per share, delivered in an approximately equal mix of cash and stock. Clearwater will also pay ...

Ademi LLP is investigating Enfusion (NYSE: ENFN) for possible breaches of fiduciary duty and other violations of law in its transaction with Clearwater. Click here to learn how to join our ...

Clearwater Analytics has agreed to acquire Enfusion in a $1.5 billion cash-and ... the world's media organizations, industry events and directly to consumers.

Enfusion shareholders will receive $5.85 in cash and $5.40 in Clearwater stock for each share, valuing the Chicago-based firm at $11.25 per share, the companies said on Monday.